Omada Health Overview
Latest ROE for Omada Health: 4.14% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow4.14%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Omada Health (OMDA) currently reports a ROE of 4.14%. That is above the sector sector average of -6.04%. Use the charts on this page to explore Omada Health's ROE history and peer comparisons.
Omada Health's ROE of 4.14% is higher than the its sector sector average of -6.04%. That is roughly 168.5% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Omada Health's current 4.14% should be judged against industry norms (sector average: -6.04%) and against OMDA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 4.14%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -6.04%. From there, open related valuation or income-statement pages for Omada Health, and consider following OMDA for alerts when major investors trade the stock.
